Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea

VANCOUVER, British Columbia, April 09, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…

Algernon Announces Positive Feedback from Health Canada for Ifenprodil COVID-19 Phase 2 Human Trial

VANCOUVER, British Columbia, April 08, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…